eHealth (EHTH)
(Delayed Data from NSDQ)
$4.86 USD
-0.17 (-3.38%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $4.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Income Statements
Fiscal Year end for eHealth, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 453 | 405 | 538 | 583 | 506 |
Cost Of Goods | 2 | 2 | 2 | 4 | 3 |
Gross Profit | 451 | 404 | 536 | 579 | 503 |
Selling & Adminstrative & Depr. & Amort Expenses | 480 | 506 | 662 | 525 | 422 |
Income After Depreciation & Amortization | -29 | -103 | -126 | 53 | 81 |
Non-Operating Income | 9 | -4 | 1 | 1 | 2 |
Interest Expense | 11 | 0 | 0 | 0 | 0 |
Pretax Income | -31 | -106 | -125 | 54 | 84 |
Income Taxes | -2 | -18 | -21 | 9 | 17 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -28 | -89 | -104 | 45 | 67 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -28 | -89 | -104 | 45 | 67 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -82 | -107 | 66 | 90 |
Depreciation & Amortization (Cash Flow) | 20 | 21 | 19 | 13 | 9 |
Income After Depreciation & Amortization | -29 | -103 | -126 | 53 | 81 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 28.02 | 27.36 | 26.78 | 27.01 | 24.54 |
Diluted EPS Before Non-Recurring Items | -2.28 | -2.69 | -2.37 | 1.69 | 3.50 |
Diluted Net EPS (GAAP) | -2.37 | -4.36 | -4.59 | 1.68 | 2.73 |
Fiscal Year end for eHealth, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 65.86 | 92.96 | 247.66 | 64.72 |
Cost Of Goods | NA | 0.00 | 0.00 | 1.11 | 0.19 |
Gross Profit | NA | 65.86 | 92.96 | 246.55 | 64.52 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 93.82 | 110.88 | 187.19 | 103.92 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -27.96 | -17.92 | 59.36 | -39.40 |
Non-Operating Income | NA | 2.34 | 2.39 | 10.08 | -0.14 |
Interest Expense | NA | 2.85 | 2.81 | 10.97 | 0.00 |
Pretax Income | NA | -28.47 | -18.33 | 58.47 | -39.53 |
Income Taxes | NA | -0.51 | -1.35 | 6.28 | -2.51 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -27.97 | -16.98 | 52.19 | -37.03 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -27.97 | -16.98 | 52.19 | -37.03 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 29.23 | 28.91 | 29.37 | 28.11 |
Diluted EPS Before Non-Recurring Items | NA | -1.23 | -0.79 | 1.42 | -1.72 |
Diluted Net EPS (GAAP) | NA | -1.33 | -0.96 | 1.50 | -1.68 |